Milnacipran versus other antidepressive agents for depression.

Milnacipran versus other antidepressive agents for depression.

BACKGROUND: Although pharmacological and psychological interventions are both effective for major depression, antidepressant drugs are frequently used as first-line treatment in primary and secondary care settings. Milnacipran, a dual serotonin-norepinephrine reuptake inhibitor (SNRI), is one of the...

Full description

Bibliographic Details
Main Authors:	Nakagawa, A, Watanabe, N, Omori, I, Barbui, C, Cipriani, A, McGuire, H, Churchill, R, Furukawa, T
Format:	Journal article
Language:	English
Published:	2009

Similar Items

Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.
by: Nakagawa, A, et al.
Published: (2008)

Mirtazapine versus other antidepressive agents for depression.
by: Watanabe, N, et al.
Published: (2011)

Escitalopram versus other antidepressive agents for depression.
by: Cipriani, A, et al.
Published: (2009)

Sertraline versus other antidepressive agents for depression.
by: Cipriani, A, et al.
Published: (2009)

Sertraline versus other antidepressive agents for depression.
by: Cipriani, A, et al.
Published: (2010)

Sertraline versus other antidepressive agents for depression
by: Cipriani, A, et al.
Published: (2010)

Fluvoxamine versus other anti-depressive agents for depression.
by: Omori, I, et al.
Published: (2010)

Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.
by: Watanabe, N, et al.
Published: (2008)

Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.
by: Watanabe, N, et al.
Published: (2010)

Citalopram versus other anti-depressive agents for depression.
by: Cipriani, A, et al.
Published: (2012)

Duloxetine versus other anti-depressive agents for depression.
by: Cipriani, A, et al.
Published: (2012)

Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis.
by: Omori, I, et al.
Published: (2009)

Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis.
by: Cipriani, A, et al.
Published: (2008)

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.
by: Cipriani, A, et al.
Published: (2009)

Paroxetine versus other anti-depressive agents for depression
by: Purgato, M, et al.
Published: (2014)

Making the best use of available evidence: the case of new generation antidepressants: a response to: are all antidepressants equal?
by: Barbui, C, et al.
Published: (2009)

Brexpiprazole versus placebo or other antidepressive agents for treating depression
by: Ralovska, S, et al.
Published: (2021)

Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
by: Philippe Courtet
Published: (2010-08-01)

Suicide, depression, and antidepressants.
by: Cipriani, A, et al.
Published: (2005)

Long-term treatment of depression with antidepressants: a systematic narrative review.
by: Furukawa, T, et al.
Published: (2007)

Fluoxetine versus other types of pharmacotherapy for depression
by: Magni, L, et al.
Published: (2013)

Experience with ixel (milnaciprane hydrochloride) treatment of poststroke depression
by: А В Gekht, et al.
Published: (2003-10-01)

Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice.
by: Cipriani, A, et al.
Published: (2007)

Fluoxetine versus other types of pharmacotherapy for depression
by: Cipriani, A, et al.
Published: (2009)

Fluoxetine versus other types of pharmacotherapy for depression.
by: Cipriani, A, et al.
Published: (2005)

Editorial Foreword - Milnacipran: recent findings in depression
by: Stuart Montgomery, et al.
Published: (2010-08-01)

Ranking antidepressants Reply
by: Cipriani, A, et al.
Published: (2009)

Antidepressants versus placebo for panic disorder in adults
by: Bighelli, I, et al.
Published: (2018)

Rapid improvement of depressive symptoms in suicide attempters following treatment with milnacipran and tricyclic antidepressants &ndash; a case series
by: Kirino E, et al.
Published: (2011-12-01)

Suicide, depression, and antidepressants - Patients and clinicians need to balance benefits and harms
by: Cipriani, A, et al.
Published: (2005)

Usefulness of milnacipran in treating phantom limb pain
by: Matsumoto Y, et al.
Published: (2012-11-01)

SSRIs versus other antidepressants for depressive disorder.
by: Geddes, J, et al.
Published: (2000)

Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder
by: Alla Avedisova, et al.
Published: (2009-07-01)

Milnacipran for the management of fibromyalgia syndrome
by: Michelle J Ormseth, et al.
Published: (2010-03-01)

Milnacipran for neuropathic pain and fibromyalgia in adults.
by: Derry, S, et al.
Published: (2012)

Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis
by: Juntao Yin, et al.
Published: (2023-11-01)

Relationship between quality of reports of antidepressant randomized controlled trials and treatment estimates: systematic review, meta-analysis, and meta-regression analysis.
by: Cipriani, A, et al.
Published: (2007)

Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis.
by: Barbui, C, et al.
Published: (2011)

Are all antidepressants really the same? The case of fluoxetine: a systematic review.
by: Cipriani, A, et al.
Published: (2006)

Effect of milnacipran on body weight in patients with fibromyalgia
by: Arnold LM, et al.
Published: (2012-10-01)